ASCI is a potential new Antigen Specific Cancer Immunotherapy approach

Welcome to the ASCI website, which is dedicated to helping patients, their families, friends and any interested readers understand about a new cancer immunotherapy approach under development by GSK.

Cancer immunotherapy has the potential, as a novel form of treatment, to improve the way our immune system fights the tumors. Cancer immunotherapy aims at stimulating and enhancing the natural immune response to tumor cells.

• Discover what is cancer immunotherapy

Antigen-Specific Cancer Immunotherapeutics or ASCI is the GSK approach to immunotherapy, it aims at educating the patients’ own immune system to fight the tumor.

• Learn more about ASCI science

ASCI is being developed as a potential new treatment for two types of cancer:

• lung cancer, specifically non-small cell lung cancer (NSCLC)
  Learn more about ASCI in the treatment of Lung Cancer
• melanoma (a type of skin cancer)
  Learn more about ASCI in the treatment of melanoma